Gilead Sciences (GILD) PT Lowered to $80 at Morgan Stanley
Morgan Stanley lowered its price target on Gilead Sciences (NASDAQ: GILD) to $80.00 (from $82.00) while maintaining a Equalweight rating.
Morgan Stanley lowered its price target on Gilead Sciences (NASDAQ: GILD) to $80.00 (from $82.00) while maintaining a Equalweight rating.